EMAIL THIS PAGE TO A FRIEND

Current opinion in infectious diseases

New developments in epidemiology, diagnosis, and treatment of fascioliasis.


PMID 22744320

Abstract

This review focuses on the recent developments in the epidemiology, burden of disease, diagnostic tests, and treatment of fascioliasis. Recent epidemiologic data suggest that either the endemic areas are expanding or disease is being recognized in areas where it was not previously observed. In addition, recent data highlight the effects of fascioliasis on childhood anemia and nutrition. Diagnosis remains problematic, but newer diagnostic tests including antibody, antigen, and DNA detection tests may facilitate earlier diagnosis. Recent studies suggest that point-of-care testing may soon be possible. Treatment with triclabendazole is effective, but resistance is emerging in livestock and may pose a threat for patients. Fascioliasis continues to emerge as an important neglected disease, with new studies highlighting the under-recognized burden of disease. Further studies are needed on burden of disease, improved diagnosis, and alternative to triclabendazole treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

32802
Triclabendazole, VETRANAL, analytical standard
C14H9Cl3N2OS